Poly Medicure Ltd Share Price Today - Poly Medicure Ltd Live Updates NSE/BSE

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open1,578.8

High1,601.1

Low1,575.1

Prev. Close1,593.8

Avg. Traded Price1,593.34

Volume45,455

MARKET DEPTH

Total bid2.00

Total ask0.00

Orders	Qty	Bid
1	2	1593.8
0	0	0
0	0	0
0	0	0
0	0	0

Ask	Qty	Orders
0	0	0
0	0	0
0	0	0
0	0	0
0	0	0

HIGH/LOW

52w

LOW/HIGH

₹1575.1010 hours ago

₹1601.109 hours ago

LOWER/UPPER CIRCUITS

₹1267.10

₹1900.50

Poly Medicure Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 13.44%, in the last year to ₹1,995.34 Cr. Its sector's average revenue growth for the last fiscal year was 20.52%.

Price to Earning Ratio,is 50.95, lower than its sector PE ratio of 51.51.

Quarterly Revenue,rose 30.3% YoY to ₹558.78 Cr. Its sector's average revenue growth YoY for the quarter was 28.04%.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 48.58%

Net profit growth 5Y CAGR : 31.92%

Poly Medicure Ltd Top mutual funds holding

SBI Healthcare Opp Fund-Reg(IDCW)

3Y Return+20.3%

NAV₹306.99

HSBC Midcap Fund-Reg(G)

3Y Return+20.2%

NAV₹447.02

About Poly Medicure Ltd.

Poly Medicure Ltd. (Polymed) is a leading Indian manufacturer and exporter of medical devices, established in 1995. The company offers a diverse portfolio of 200+ products spanning infusion therapy, anaesthesia, oncology, urology, and gastroenterology, and exports to more than 125 countries, supported by state-of-the-art manufacturing facilities that adhere to international quality standards and certifications. Polymed manufactures and supplies devices across infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, vascular access, surgery and wound drainage, dialysis and renal care, diagnostics, transfusion systems, veterinary medical devices and others.

The company states it is the largest exporter of medical devices from India, with 70% of sales from exports to highly regulated developed markets like the EU, LATAM and South-East Asia; it is also among the top three IV cannula manufacturers globally and the first indigenous dialyzer manufacturer. Polymed’s footprint includes multiple units in Faridabad (Haryana), Haridwar (Uttarakhand) and Jaipur (SEZ, Rajasthan), along with overseas sites in Amaro, Italy; Laiyang–Qingdao, China; and Assuit, Egypt; the R&D Centre is located in Faridabad. As on the latest year, the company had 3 subsidiaries (and 3 step-subsidiaries) and employed 3,082 people.

Poly Medicure Ltd.’s Business Segments

Sales mix: Exports 70%; Domestic 30%.

Poly Medicure Ltd.’s Key Management

D. R. Mehta – Chairman

Himanshu Baid – Managing Director

Rishi Baid – Joint Managing Director

Naresh Vijayvargiya – Chief Financial Officer

Avinash Chandra – Company Secretary

These designations are as presented in the Annual Report’s statutory sections and financial statement sign-offs.

Latest Updates on Poly Medicure Ltd.

Product and technology: Recent launches include dialyzers, dialysis machines, safety Huber needles, PICC catheters, arterial and diagnostic catheters, guidewires, and pre-filled syringes; the company highlights that it is the first Indian firm to indigenously manufacture dialyzers.

R&D and intellectual property: Polymed reports being granted 334 patents globally (including in the USA, Europe, Brazil, Thailand, Japan and Australia) and maintains an R&D Centre equipped for rapid prototyping (3D printing), process validation and product customisation.

Recognitions: Recent honours include Best Healthcare Brands 2024 (ET Edge), Top 75 Industrial Innovative Company of the Year 2024 and Industrial Intellectual Property Awards 2024 (CII), Medical Devices Provider of the Year 2025 (Financial Express), and Healthcare Entrepreneur of the Year 2025 for the Managing Director, Himanshu Baid (Financial Express). The company also cites recognition such as The Next 500 Companies 2023 (Fortune India) and Best Company for Technology Innovation in Healthcare 2023 (ASSOCHAM).

Market engagement: The company participated in leading global exhibitions, including Arab Health (Dubai), Medica (Germany), Hospitalar (Brazil), FIME (Miami) and ExpoMed (Turkey).

Similar stocks

LENSKART₹646.50+3.80 (0.59%)

MOLBIO₹1574.40+145.10 (10.15%)

QLINE₹628.85+30.55 (5.11%)

3BBLACKBIO₹1446.40-10.10 (0.69%)

LAXMIDENTL₹184.72-6.08 (3.19%)

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

What was Poly Medicure Ltd's low today on the NSE?

The intraday low for Poly Medicure Ltd on the NSE today was ₹1,575.10. The stock's 52-week low stands at ₹1,182.00, recorded on 30 Mar 2026. Today's low is 33.26% above the 52-week low, indicating the stock is trading well above its yearly lows.

What was today's high for Poly Medicure Ltd share?

The intraday high for Poly Medicure Ltd on the NSE today (16 Oct 2026) was ₹1,601.10. This compares to the 52-week high of ₹2,094.30 recorded on 11 Nov 2025. Today's high was -23.55% below the 52-week high.

How much return has Poly Medicure Ltd given in the last 52 weeks?

Poly Medicure Ltd has delivered -17.53% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,094.30 on 11 Nov 2025 and a 52-week low of ₹1,182.00 on 30 Mar 2026. It is currently trading at ₹1,585.10 as of 16 Oct 2026.

What is the highest Poly Medicure Ltd share price ever recorded and when?

The all-time high (ATH) for Poly Medicure Ltd was ₹3,128.90, recorded on 01 Nov 2024. At the current price of ₹1,585.10, the stock is trading 49.34% below its all-time high. The all-time low recorded was ₹24.83 on 28 Dec 2011.

What is the return of Poly Medicure Ltd in the past 5 years?

Poly Medicure Ltd has delivered a 65.03% absolute return over the past 5 years, equivalent to a CAGR of 10.54% per annum. The stock was priced at ₹960.49 in Oct 2021 and has risen to ₹1,585.10 as of 16 Oct 2026. An investment of ₹1,00,000 in Poly Medicure Ltd five years ago would be worth ₹1,65,030.00 today.

Has Poly Medicure Ltd offered any dividend in the past 5 years?

Yes,Poly Medicure Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 15.50 per share between FY2022 and FY2026, with the most recent dividend of ₹3.50 per share for May 26, with an ex-dividend date of 28 Aug 2026. At the current market price of ₹1,585.10, the trailing dividend yield of Poly Medicure Ltd stands at 7.00%.

How much return has Poly Medicure Ltd given in the last 3 months?

Poly Medicure Ltd has delivered a return of -8.06% over the last 3 months. The stock was trading at ₹1,722.70 on 16 Jul 2026 and is currently at ₹1,585.10 as of 16 Oct 2026, reflecting a Loss of ₹137.60 per share over this period.

How much return has Poly Medicure Ltd given in the last 6 months?

Over the last 6 months, Poly Medicure Ltd has given a return of 5.81%. The stock was priced at ₹1,496.90 on 16 Apr 2026 and has Rise to ₹1,585.10 as of 16 Oct 2026, a change of ₹88.20 per share.

What is the share price of Poly Medicure Ltd?

As of 16 Oct 2026, the share price of Poly Medicure Ltd is ₹1,585.10 on the NSE and ₹1,601.25 on the BSE. The stock opened at ₹1,578.80, touched a high of ₹1,601.10 and a low of ₹1,575.10 during today's session.

What were the most recent reported sales and net income of Poly Medicure Ltd?

For Q1 FY27, Poly Medicure Ltd reported: Revenue (Net Sales): ₹4310.99 Cr - Down -2.69% year-on-year from ₹4430.15 Cr in Q4 FY26. Net Income (PAT): ₹881.24 Cr - Up 9.31% year-on-year from ₹806.22 Cr in Q4 FY26.